http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. India's Supreme Court is to rule Monday on a landmark patent case involving Swiss drugmaker Novartis AG that focuses on demands by major companies that their investments be protected, against Indian companies that say they should be allowed to continue producing cheaper generic versions of many lifesaving medicines. http://medicalxpress.com/news/2013-03-india-court-novartis-judgment.html Medications Sun, 31 Mar 2013 09:20:01 EST news283939647 The Supreme Court will soon decide whether generic drug manufacturers can be sued in state court for a drug's design defects after federal officials approved the brand-name version. http://medicalxpress.com/news/2013-03-court-drug-maker-sued.html Medications Tue, 19 Mar 2013 13:49:41 EST news282919775 India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important precedent for getting inexpensive lifesaving medicines to the poor. http://medicalxpress.com/news/2013-03-india-bayer-plea-cheap-cancer.html Medications Tue, 05 Mar 2013 04:10:42 EST news281679032 (HealthDay)—Seeking to ease potentially dangerous shortages of a key cancer drug, the U.S. Food and Drug Administration on Monday announced it had fast-tracked the approval of the first generic form of one such medication, Doxil (doxorubicin). http://medicalxpress.com/news/2013-02-ease-shortage-fda-fast-tracks-cancer.html Medications Mon, 04 Feb 2013 17:30:01 EST news279218312 (HealthDay)—The first generic version of the cancer drug Doxil (doxorubicin hydrochloride liposome injection) has been approved by the U.S. Food and Drug Administration, which says the action should help relieve shortages of the brand-name medication. http://medicalxpress.com/news/2013-02-version-cancer-drug-doxil.html Medications Mon, 04 Feb 2013 17:00:05 EST news279217910 Despite U.S. Food and Drug Administration regulations requiring generic medications to carry identical warnings to those on corresponding brand-name products, a study by Regenstrief Institute researchers has found that more than two-thirds of generic drugs have safety-warning labels that differ from the equivalent brand-name drug. http://medicalxpress.com/news/2012-12-regenstrief-drugs-incorrect-safety.html Medications Thu, 13 Dec 2012 13:44:24 EST news274628656 Canada's top court on Thursday stripped Pfizer of its patent for Viagra, saying the pharmaceutical giant failed in the patent to identify the active compound in the drug. http://medicalxpress.com/news/2012-11-canada-high-court-voids-pfizer.html Medications Thu, 08 Nov 2012 15:09:56 EST news271609777 Thailand has approved an affordable generic version of the anti-impotence drug Viagra to go on sale next week, as the country looks to combat rampant counterfeit production, officials said Wednesday. http://medicalxpress.com/news/2012-09-thailand-viagra-drug.html Medications Wed, 26 Sep 2012 06:58:46 EST news267861522 The US Supreme Court ruled Tuesday that generic drug makers can challenge big-name pharmaceutical firms in court to stop them from broadening the scope of their patent descriptions. http://medicalxpress.com/news/2012-04-supreme-court-drug-makers.html Medications Wed, 18 Apr 2012 00:33:23 EST news253927980 The substitution of brand-name antiepileptic drugs with cheaper generic equivalents has been an ongoing point of contention among doctors, federal officials and people with epilepsy. http://medicalxpress.com/news/2012-02-antiepileptic-drugs-seizures.html Medications Fri, 17 Feb 2012 16:34:30 EST news248718850 US officials sought a "groundbreaking" injunction against Indian drug giant Ranbaxy on Wednesday, saying the maker of the first generic version of cholesterol-lowering Lipitor has failed to meet US safety guidelines. http://medicalxpress.com/news/2012-01-injunction-indian-drug-firm-ranbaxy.html Medications Thu, 26 Jan 2012 04:26:32 EST news246774363 Indian pharmaceutical giant Ranbaxy won US regulatory approval to make the first generic version of cholesterol lowering drug Lipitor, a Pfizer product whose patent expired Wednesday. http://medicalxpress.com/news/2011-12-india-ranbaxy-lipitor.html Medications Thu, 01 Dec 2011 02:11:07 EST news241927215 Pfizer's patent on the best-selling drug of all-time, the cholesterol-lowering medication Lipitor, expired on Wednesday, opening the path to generic competitors for America's most popular medication. http://medicalxpress.com/news/2011-11-pfizer-blockbuster-drug-lipitor.html Medications Wed, 30 Nov 2011 13:31:46 EST news241882296 South Korea's anti-trust agency has fined drugmaker GlaxoSmithKline three billion won ($2.6 million) for conspiring with a Seoul rival over the sale of drugs, an official said Monday. http://medicalxpress.com/news/2011-10-drug-firm-gsk-fined-million.html Medications Mon, 24 Oct 2011 04:33:14 EST news238649580 When pharmacies, doctors' offices and homes were destroyed by the tornado in Joplin, Mo., so were the medication records of many patients. Pharmacists who helped out report that many people could not recall the names of their prescription drugs or the dosages they were taking. http://medicalxpress.com/news/2011-06-drug-prescriptions-users.html Medications Mon, 27 Jun 2011 13:50:01 EST news228398682